Back to Search
Start Over
Viable virus shedding during SARS-CoV-2 reinfection.
- Source :
-
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Jul; Vol. 9 (7), pp. e56-e57. Date of Electronic Publication: 2021 May 05. - Publication Year :
- 2021
-
Abstract
- Competing Interests: All authors declare no competing interests. This study was supported by the Defense Health Agency and Defense Advanced Research Projects Agency. AGL, DRS, CG, DLW, HWC, RAL, SEL, JM, EN, CKP, ESA, MS, VAS, PS, and MT are military service members or government service employees. This work was prepared as part of their official duties. Title 17, US Code §105 provides that copyright protection under this title is not available for any work of the US Government. Title 17, US code §101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person's official duties. The views expressed in the article are those of the authors and do not necessarily express the official policy and position of the US Navy, the Department of Defense, the US Government, or the institutions affiliated with the authors.
- Subjects :
- Humans
Reinfection
Virus Shedding
COVID-19
SARS-CoV-2
Subjects
Details
- Language :
- English
- ISSN :
- 2213-2619
- Volume :
- 9
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- The Lancet. Respiratory medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33964243
- Full Text :
- https://doi.org/10.1016/S2213-2600(21)00219-8